• Prevalence of Counterfeit or Substandard Antibiotics in Developing Countries 07-08-2014

HealthTech Report, April 2014

Counterfeit and substandard drugs are particularly prevalent in low-resource settings due to the lack of regulatory oversight. In an effort to further the work of the UN Commission on Life-Saving Commodities Technical Reference Team on injectable antibiotics, we undertook this literature review to describe existing evidence on this issue for the antimicrobials currently being considered by WHO for outpatient treatment of neonatal sepsis in low-resource settings. Because the work of the UN Commission on Life-Saving Commodities currently focuses on sub-Saharan Africa, we have concentrated this literature review on evidence of counterfeit and substandard antibiotics in Africa.